Clinical Trials Browser

INDUSTRY × bemarituzumab × 1 year × Clear all

NCT05052801 2026-02-19

FORTITUDE-101

Phase 3 Active not recruiting

Gastrointestinal

Stomach Neoplasms

NCT05111626 2025-12-15

FORTITUDE-102

Phase 3 Active not recruiting

Gastrointestinal

Stomach Neoplasms

NCT05322577 2025-12-05

FORTITUDE-103

Phase 1/2 Active not recruiting

Gastrointestinal

Stomach Neoplasms

NCT05267470 2025-03-25

FORTITUDE-201

Phase 1 Terminated

74 enrolled 22 charts

Squamous-Cell Non-Small-Cell Lung Cancer